DashboardAll companies
Run this on your own research
Run this on your own research
Healthcare · Medical Instruments & Supplies

West Pharmaceutical Services, Inc.

WSTNYSE$392.15−$1.88 (−0.48%)Market closed

Price Chart

Daily

Key facts

Market Cap
$27.76B
P/E
57.4x
P/B
8.93x
ROE
16.9%

West Pharmaceutical Services, Inc.

Healthcare · Medical Instruments & Supplies · FY 2025

West Pharmaceutical Services, Inc. is a leading provider of innovative solutions for injectable drug administration, operating in the life sciences tools and services industry. Established in 1923, the company specializes in the design and manufacture of containment and delivery systems for injectable pharmaceuticals and healthcare products. Its product portfolio primarily includes components and systems such as stoppers, seals, vials, and syringes, serving pharmaceutical, biotechnology, and medical device companies globally. These products are critical to ensuring the safety, efficacy, and integrity of medicines, particularly in sterile environments. West Pharmaceutical Services plays a vital role in supporting the pharmaceutical supply chain, addressing the stringent regulatory demands of the healthcare sector. The company is recognized for driving innovation in parenteral drug packaging and delivery, contributing to advances in both drug safety and patient outcomes. With a significant presence across international markets, West Pharmaceutical Services is regarded as a key partner for industry leaders engaged in the development and distribution of injectable therapies.

CEO
Mr. Eric M. Green
Employees
10,600

Company Statistics

Valuation

P/E
57.4x
P/B
8.93x
P/S
9.22x
EV/EBITDA
33.9x
P/FCF
60.5x

Margins

Gross
35.9%
EBITDA
26.8%
Operating
20.7%
Pre-Tax
19.5%
Net
16.1%

Returns

ROA
12.5%
ROE
16.9%
ROIC
15.2%

Growth (CAGR)

Rev 3Yr
2.1%
Rev 5Yr
7.4%
Op Inc 3Yr
−5.8%
Net Inc 3Yr
−5.5%

Financial Health

Cash & Cash Equivalents
$791.3M
Net Debt
$302.7M
Debt/Equity
34.4%
Interest Cov
—

Profile

Revenue
$3.07B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
West Pharmaceutical Services, Inc. (WST) Stock Forecast 2026 $392.15 — Price, Financials & Analyst Targets | AlphaLenz